ARCHIVES

Leter: Payers Must Determine Appropriate Therapies

This article is from The Cancer Letter archive.

Vol. 22 No. 29 | July 19, 1996

Download PDF Visit The Full Archive

Related Articles

NCI Plans Phase-Out Of K04 Career Awards

March 3, 1995

HHS Reinvention May Include Privatizing Of NIH Clinical Center

May 19, 1995

NCI To Offer Expanded Access To Oxaliplatin

May 31, 2002

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

Neulasta Reduces Incidence Of Febrile Neutropenia

February 22, 2013

Quality Oncology Wins Pilot Contract For Cancer Management In Fla.

July 27, 2001